IFNbeta lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS.

Source:http://linkedlifedata.com/resource/pubmed/id/12525717

Neurology 2003 Jan 14 60 1 52-7

Download in:

View as

General Info

PMID
12525717